148 related articles for article (PubMed ID: 16891251)
1. Metabolism of the recently encountered designer drug, methylone, in humans and rats.
Kamata HT; Shima N; Zaitsu K; Kamata T; Miki A; Nishikawa M; Katagi M; Tsuchihashi H
Xenobiotica; 2006 Aug; 36(8):709-23. PubMed ID: 16891251
[TBL] [Abstract][Full Text] [Related]
2. Identification of three new phase II metabolites of a designer drug methylone formed in rats by N-demethylation followed by conjugation with dicarboxylic acids.
Židková M; Linhart I; Balíková M; Himl M; Dvořáčková V; Lhotková E; Páleníček T
Xenobiotica; 2018 Jun; 48(6):618-625. PubMed ID: 28665175
[TBL] [Abstract][Full Text] [Related]
3. An integrated pharmacokinetic and pharmacodynamic study of a new drug of abuse, methylone, a synthetic cathinone sold as "bath salts".
López-Arnau R; Martínez-Clemente J; Carbó Ml; Pubill D; Escubedo E; Camarasa J
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():64-72. PubMed ID: 23603357
[TBL] [Abstract][Full Text] [Related]
4. Isolation, identification and excretion profile of the principal urinary metabolite of the recently banned designer drug 1-(3-trifluoromethylphenyl)piperazine (TFMPP) in rats.
Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nakajima K; Inoue H; Kishi T; Tsuchihashi H
Xenobiotica; 2005 Jan; 35(1):107-16. PubMed ID: 15788372
[TBL] [Abstract][Full Text] [Related]
5. Designer drugs 2,5-dimethoxy-4-bromo-amphetamine (DOB) and 2,5-dimethoxy-4-bromo-methamphetamine (MDOB): studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.
Ewald AH; Fritschi G; Bork WR; Maurer HH
J Mass Spectrom; 2006 Apr; 41(4):487-98. PubMed ID: 16470568
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and the urinary excretion profile of the recently scheduled designer drug N-Benzylpiperazine (BZP) in the rat.
Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nakajima K; Inoue H; Kishi T; Tsuchihashi H
J Anal Toxicol; 2006; 30(1):38-43. PubMed ID: 16620530
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic Profiles and Pharmacodynamic Effects for Methylone and Its Metabolites in Rats.
Elmore JS; Dillon-Carter O; Partilla JS; Ellefsen KN; Concheiro M; Suzuki M; Rice KC; Huestis MA; Baumann MH
Neuropsychopharmacology; 2017 Feb; 42(3):649-660. PubMed ID: 27658484
[TBL] [Abstract][Full Text] [Related]
8. Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry.
Meyer MR; Wilhelm J; Peters FT; Maurer HH
Anal Bioanal Chem; 2010 Jun; 397(3):1225-33. PubMed ID: 20333362
[TBL] [Abstract][Full Text] [Related]
9. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nishikawa M; Nakajima K; Tsuchihashi H
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):315-22. PubMed ID: 15833296
[TBL] [Abstract][Full Text] [Related]
10. New designer drug 2,5-dimethoxy-4-ethylthio-beta-phenethylamine (2C-T-2): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.
Theobald DS; Staack RF; Puetz M; Maurer HH
J Mass Spectrom; 2005 Sep; 40(9):1157-72. PubMed ID: 16041763
[TBL] [Abstract][Full Text] [Related]
11. Sweat Testing for the Detection of Methylone after Controlled Administrations in Humans.
Di Giorgi A; Sprega G; Poyatos L; Papaseit E; Pérez-Mañá C; Di Trana A; Varì MR; Busardò FP; Pichini S; Zaami S; Lo Faro AF; Farré M
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108557
[TBL] [Abstract][Full Text] [Related]
12. Identification of phase I and II metabolites of the new designer drug α-pyrrolidinohexiophenone (α-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
Paul M; Bleicher S; Guber S; Ippisch J; Polettini A; Schultis W
J Mass Spectrom; 2015 Nov; 50(11):1305-17. PubMed ID: 26505776
[TBL] [Abstract][Full Text] [Related]
13. The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.).
Meyer MR; Mauer S; Meyer GM; Dinger J; Klein B; Westphal F; Maurer HH
Drug Test Anal; 2014; 6(7-8):746-56. PubMed ID: 24124065
[TBL] [Abstract][Full Text] [Related]
14. In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry.
Tyrkkö E; Pelander A; Ketola RA; Ojanperä I
Anal Bioanal Chem; 2013 Aug; 405(21):6697-709. PubMed ID: 23797910
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of the designer drug α-pyrrolidinobutiophenone (α-PBP) in humans: identification and quantification of the phase I metabolites in urine.
Matsuta S; Shima N; Kamata H; Kakehashi H; Nakano S; Sasaki K; Kamata T; Nishioka H; Miki A; Katagi M; Zaitsu K; Sato T; Tsuchihashi H; Suzuki K
Forensic Sci Int; 2015 Apr; 249():181-8. PubMed ID: 25703013
[TBL] [Abstract][Full Text] [Related]
16. 2-methiopropamine, a thiophene analogue of methamphetamine: studies on its metabolism and detectability in the rat and human using GC-MS and LC-(HR)-MS techniques.
Welter J; Meyer MR; Wolf EU; Weinmann W; Kavanagh P; Maurer HH
Anal Bioanal Chem; 2013 Apr; 405(10):3125-35. PubMed ID: 23361230
[TBL] [Abstract][Full Text] [Related]
17. LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques.
Caspar AT; Westphal F; Meyer MR; Maurer HH
Anal Bioanal Chem; 2018 Jan; 410(3):897-912. PubMed ID: 28762065
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites.
Kamata T; Katagi M; Kamata HT; Miki A; Shima N; Zaitsu K; Nishikawa M; Tanaka E; Honda K; Tsuchihashi H
Drug Metab Dispos; 2006 Feb; 34(2):281-7. PubMed ID: 16280455
[TBL] [Abstract][Full Text] [Related]
19. Lefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS.
Wink CS; Meyer GM; Wissenbach DK; Jacobsen-Bauer A; Meyer MR; Maurer HH
Drug Test Anal; 2014 Oct; 6(10):1038-48. PubMed ID: 24591097
[TBL] [Abstract][Full Text] [Related]
20. Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MS(n) techniques.
Welter J; Kavanagh P; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 Feb; 407(5):1371-88. PubMed ID: 25471293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
